1. Gandy S, DeKosky ST . Toward the treatment and prevention of Alzheimer’s disease: rational strategies and recent progress. Annu Rev Med 2013; 64: 367–383.
2. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I . Tau in Alzheimer disease and related tauopathies. Curr Alz Res 2010; 7: 656–664.
3. Chu J, Praticò D . 5-Lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann Neurol 2011; 69: 34–46.
4. Murphy RC, Gijon MA . Biosynthesis and metabolism of leukotrienes. Biochem J 2007; 405: 379–395.
5. Chu J, Pratico D . Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model. J Neuroinflammation 2012; 9: 127.